▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2440185546875
▁pain 2.71484375
▁and 0.294921875
▁dem 7.14453125
oral 3.392578125
ization 0.1217041015625
. 1.046875
▁Chron 4.515625
ic 0.0032444000244140625
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.60546875
▁accompanied 2.984375
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.3955078125
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.341796875
▁person 0.69140625
’ 0.876953125
s 0.001071929931640625
▁ability 1.3916015625
▁to 0.036834716796875
▁receive 6.84375
▁joy 3.732421875
▁and 1.376953125
▁satisfaction 3.255859375
▁from 0.86572265625
▁life 0.7919921875
. 0.2283935546875
▁The 1.64453125
▁research 2.6875
▁investig 5.40625
ates 0.38720703125
▁the 0.38720703125
▁development 6.15625
▁of 0.1458740234375
▁de 3.841796875
pression 0.45849609375
▁and 1.3544921875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.6044921875
▁patients 1.48046875
▁receiving 5.83203125
▁ph 5.48046875
arma 3.224609375
ce 0.01218414306640625
ut 6.604194641113281e-05
ical 0.0064239501953125
▁op 4.64453125
io 0.09832763671875
ids 0.440185546875
▁and 2.4921875
▁medical 4.05859375
▁mar 1.75
iju 0.0010881423950195312
ana 4.851818084716797e-05
▁( 2.958984375
MM 1.2978515625
) 2.8984375
▁as 2.44140625
▁severe 9.9921875
▁pain 0.78271484375
kill 2.65625
ers 0.0005288124084472656
. 0.2169189453125
▁It 3.259765625
▁comp 4.98046875
ares 0.008392333984375
▁the 0.59033203125
▁effic 4.30859375
acy 0.0018768310546875
▁of 0.2039794921875
▁pres 6.08984375
cri 1.9091796875
ptions 1.451171875
▁and 1.927734375
▁exam 4.49609375
ines 0.00995635986328125
▁the 0.47314453125
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.5849609375
tre 1.9677734375
at 0.0017747879028320312
ment 0.004730224609375
▁de 1.6396484375
pression 0.081298828125
. 1.384765625
<0x0A> 0.767578125
There 4.6640625
▁is 1.1904296875
▁currently 5.5546875
▁a 1.0595703125
▁severe 4.9296875
▁lack 1.8564453125
▁of 0.014617919921875
▁information 2.271484375
▁about 1.162109375
▁the 0.47021484375
▁effects 3.1015625
▁of 0.0631103515625
▁op 3.08203125
i 3.7109375
ates 0.011688232421875
. 3.380859375
▁They 4.52734375
▁manage 8.40625
▁pain 3.39453125
▁successfully 5.81640625
, 0.97412109375
▁but 0.234375
▁the 2.478515625
▁past 9.0546875
▁few 2.25
▁dec 1.248046875
ades 0.0006232261657714844
▁indicated 7.015625
▁the 1.73828125
▁growing 3.603515625
▁regarding 13.9765625
▁concern 6.671875
▁op 9.59375
iate 1.521484375
▁ab 1.82421875
use 0.0256500244140625
▁in 3.58984375
▁forms 9.0
▁of 0.32275390625
▁over 3.470703125
d 0.13232421875
ose 0.311767578125
▁and 0.8525390625
▁add 0.84228515625
iction 0.02313232421875
. 0.18408203125
▁A 4.0234375
▁more 5.046875
▁manage 8.0078125
able 0.001766204833984375
▁and 2.1640625
▁sa 2.16015625
fer 0.00020301342010498047
▁alternative 1.4609375
▁might 5.08203125
▁be 0.11590576171875
▁medical 1.5126953125
▁mar 0.1611328125
iju 0.0010213851928710938
ana 0.00014019012451171875
. 0.90625
▁However 3.482421875
, 0.00530242919921875
▁the 1.7421875
▁legal 4.02734375
▁status 1.1318359375
▁and 3.16015625
▁novel 9.84375
ty 0.1512451171875
▁of 0.1611328125
▁this 2.3046875
▁do 9.609375
▁drug 6.140625
▁not 7.3359375
▁allow 1.4677734375
▁finding 7.0859375
▁a 2.37109375
▁large 2.736328125
▁number 0.8232421875
▁of 0.007068634033203125
▁studies 1.369140625
▁on 1.818359375
▁its 1.0068359375
▁effect 2.33203125
iveness 0.2418212890625
. 0.62646484375
▁Specifically 8.859375
, 0.068359375
▁it 2.640625
▁concerns 4.9375
▁the 0.8623046875
▁emot 6.56640625
ional 0.0196533203125
▁condition 4.546875
▁of 0.25341796875
▁patients 0.6904296875
▁experien 5.48046875
cing 1.7642974853515625e-05
▁pain 1.9541015625
. 0.6962890625
▁chron 14.515625
ic 0.01200103759765625
▁This 8.6640625
▁research 2.373046875
▁paper 3.82421875
▁a 2.294921875
ims 0.0010156631469726562
▁to 0.12408447265625
▁analyze 3.30078125
▁levels 9.59375
▁of 0.04736328125
▁de 0.5283203125
pression 0.02777099609375
▁and 0.204833984375
▁anx 0.035919189453125
iety 0.0006866455078125
▁among 0.83154296875
▁people 2.38671875
▁receiving 2.357421875
▁ther 6.3515625
apy 0.103759765625
▁by 4.6015625
▁comparing 8.6015625
▁the 1.52734375
▁effects 2.16796875
▁of 0.03448486328125
▁ph 2.97265625
arma 0.042144775390625
ce 0.004741668701171875
ut 0.00017368793487548828
ical 0.00494384765625
▁op 0.170654296875
io 0.68603515625
ids 0.037384033203125
▁and 0.265869140625
▁MM 0.56396484375
. 0.286376953125
<0x0A> 0.5
The 0.7822265625
▁study 1.7353515625
▁was 2.341796875
▁conducted 0.65234375
▁in 1.26171875
▁the 1.396484375
▁form 2.623046875
▁of 0.004772186279296875
▁collection 11.625
▁and 0.80810546875
▁analysis 0.438232421875
▁of 0.0197906494140625
▁statistical 3.681640625
▁data 0.132080078125
. 0.880859375
▁Part 5.09765625
icip 0.2061767578125
ants 0.06536865234375
▁were 0.712890625
▁rec 3.734375
ru 0.0013866424560546875
ited 0.0002472400665283203
▁for 4.02734375
▁six 6.70703125
▁at 10.578125
▁months 10.6796875
▁two 5.3046875
▁major 4.8046875
▁pain 3.21484375
▁relief 2.818359375
▁cent 1.3603515625
ers 0.034149169921875
▁in 0.8466796875
▁Israel 4.9921875
. 0.37646484375
▁The 1.2314453125
▁research 2.517578125
ers 1.380859375
▁used 2.09375
▁The 6.83203125
▁De 2.943359375
pression 0.0266571044921875
▁Module 6.86328125
▁of 0.76318359375
▁the 0.1925048828125
▁Pat 3.466796875
ient 0.01042938232421875
▁Health 0.034820556640625
▁Question 0.0233917236328125
naire 0.028717041015625
▁and 2.76953125
▁the 0.7255859375
▁General 1.1865234375
ized 0.62451171875
▁An 0.00791168212890625
x 0.00019657611846923828
iety 0.0005574226379394531
▁Dis 0.1773681640625
order 0.0242156982421875
▁Sc 1.47265625
ale 0.0026683807373046875
▁to 1.0185546875
▁interview 7.55859375
▁participants 2.537109375
, 4.40625
▁evaluate 4.69921875
▁their 0.5986328125
▁answers 4.44140625
, 0.397705078125
▁and 0.041473388671875
▁conduct 5.0546875
▁the 1.814453125
▁study 2.42578125
. 0.1143798828125
▁To 4.7578125
▁specifically 9.8515625
▁evaluate 3.1328125
▁and 5.06640625
▁compare 0.57763671875
▁the 0.400634765625
▁prob 10.0078125
abilities 0.0838623046875
▁of 0.08734130859375
▁de 0.9287109375
pression 0.039276123046875
▁or 4.41015625
▁anx 0.05615234375
iety 0.0008516311645507812
▁among 1.5068359375
▁the 2.125
▁diverse 9.765625
▁groups 0.7919921875
, 0.70947265625
▁the 0.4306640625
▁study 2.705078125
▁used 1.2685546875
▁multiple 5.3828125
▁log 0.595703125
istic 0.027984619140625
▁regression 0.272705078125
▁analysis 1.263671875
▁and 2.884765625
▁chose 8.5
▁medical 6.11328125
▁mar 0.093994140625
iju 0.0018815994262695312
ana 0.00011742115020751953
▁as 0.60302734375
▁the 0.93408203125
▁control 2.76953125
▁group 0.5927734375
. 0.2548828125
<0x0A> 0.462158203125
This 4.05078125
▁type 6.19921875
▁of 0.01198577880859375
▁study 1.3779296875
▁the 9.3515625
▁is 4.35546875
▁most 4.6484375
▁reve 7.578125
aling 0.0123748779296875
▁and 2.412109375
▁inclus 7.7265625
ive 0.002460479736328125
, 2.947265625
▁as 1.529296875
▁it 0.463134765625
▁contains 4.4609375
▁direct 6.48828125
▁responses 5.75
▁from 0.5615234375
▁a 3.453125
▁large 1.0234375
▁number 0.51513671875
▁of 0.011383056640625
▁participants 1.134765625
. 0.69287109375
▁All 5.00390625
▁tools 8.1640625
▁in 5.6171875
▁the 0.77587890625
▁form 4.01953125
▁of 0.061187744140625
▁question 0.7216796875
na 0.022064208984375
ires 0.0006318092346191406
▁and 1.24609375
▁scales 2.56640625
▁have 3.470703125
▁already 4.11328125
▁been 0.43115234375
▁used 2.275390625
▁and 1.7412109375
▁proved 2.470703125
▁their 1.357421875
▁effic 2.537109375
acy 0.004337310791015625
▁for 3.59765625
▁collect 4.10546875
ing 0.004638671875
▁analyt 7.21875
ical 0.1011962890625
▁data 0.2021484375
. 0.39501953125
▁It 3.26953125
▁helps 4.0625
▁to 0.68701171875
▁system 6.83984375
at 0.591796875
ize 0.00394439697265625
▁and 1.2705078125
▁class 4.71875
ify 0.0036373138427734375
▁distinct 8.421875
▁kinds 6.3359375
▁of 0.019989013671875
▁information 2.064453125
▁for 4.1171875
▁subsequent 4.96875
▁un 8.5078125
comp 4.30078125
licated 0.022125244140625
▁services 12.265625
. 0.50244140625
▁Thus 4.8046875
, 0.01285552978515625
▁research 4.30859375
ers 0.2548828125
▁can 1.728515625
▁compare 2.728515625
▁the 1.0546875
▁effects 2.931640625
▁of 0.10760498046875
▁medic 3.77734375
ations 0.70263671875
▁on 1.671875
▁patients 2.103515625
▁of 4.10546875
▁diverse 3.33984375
▁age 1.998046875
▁groups 2.115234375
, 0.74462890625
▁background 3.939453125
s 0.13916015625
, 0.0270538330078125
▁physical 5.61328125
▁conditions 1.3681640625
, 0.0533447265625
▁emot 6.43359375
ional 0.027862548828125
▁states 1.31640625
, 0.0623779296875
▁and 0.39404296875
▁so 2.501953125
▁on 0.205322265625
. 0.072509765625
<0x0A> 0.84326171875
The 0.73681640625
▁analysis 4.00390625
▁of 0.767578125
▁any 9.359375
▁human 6.98828125
▁reaction 4.30078125
▁has 4.79296875
▁a 1.734375
▁high 3.25
▁potential 3.28515625
▁of 1.9462890625
▁subject 2.740234375
iveness 3.515625
▁and 1.2890625
▁bias 1.8447265625
, 2.1640625
▁especially 2.38671875
▁regarding 3.81640625
▁people 5.13671875
▁in 3.794921875
▁severe 2.591796875
▁pain 0.5576171875
▁and 2.296875
▁un 5.5859375
stable 1.1142578125
▁emot 0.6279296875
ional 0.0692138671875
▁condition 2.431640625
. 0.05706787109375
▁Perhaps 8.1015625
▁some 4.9609375
▁patients 2.10546875
▁tend 4.78125
▁to 0.0146636962890625
▁ex 2.087890625
agger 0.00963592529296875
ate 0.0028247833251953125
▁their 0.98388671875
▁de 3.2265625
press 1.8427734375
ive 0.07568359375
▁state 2.521484375
▁or 1.6025390625
▁vice 5.609375
▁vers 0.03753662109375
a 0.00011980533599853516
, 1.17578125
▁de 7.41796875
- 2.720703125
emph 0.47607421875
as 0.003772735595703125
ize 0.0706787109375
▁serious 6.76171875
▁difficulties 5.58203125
. 0.83935546875
▁Because 6.32421875
▁the 2.556640625
▁survey 4.703125
▁responses 6.8359375
▁were 1.5107421875
▁thoroughly 8.7578125
▁anonymous 2.71484375
, 0.294189453125
▁the 1.2587890625
▁research 1.0693359375
ers 0.206787109375
▁were 2.552734375
▁unable 2.947265625
▁to 0.0038242340087890625
▁carefully 7.62890625
▁analyze 2.75390625
▁each 2.486328125
▁patient 2.626953125
’ 0.5927734375
s 0.0015535354614257812
▁reaction 4.0546875
▁and 1.2978515625
▁compare 3.642578125
▁it 0.86083984375
▁to 0.64013671875
▁the 0.97021484375
▁actual 4.3828125
▁of 9.1171875
▁states 7.515625
▁condition 6.2578125
. 0.359619140625
▁More 6.43359375
▁accurate 3.201171875
▁answers 4.5703125
▁could 2.0390625
▁be 0.78759765625
▁obtained 1.0087890625
▁by 1.4833984375
▁professional 6.06640625
▁psych 1.1357421875
olog 0.366455078125
ists 0.0018262863159179688
▁via 6.89453125
▁personal 2.572265625
▁communication 4.1015625
▁and 1.9267578125
▁behavior 6.296875
al 0.288330078125
▁analysis 2.0859375
. 0.2369384765625
▁However 3.052734375
, 0.0015535354614257812
▁this 1.4091796875
▁method 2.36328125
▁of 2.470703125
▁research 1.8896484375
▁is 1.1337890625
▁more 2.68359375
▁way 12.9921875
▁resource 5.7734375
- 0.55859375
int 1.095703125
ensive 0.04736328125
▁and 0.4580078125
▁energy 10.6953125
- 0.158447265625
consum 0.390869140625
ing 0.0027675628662109375
. 0.67431640625
<0x0A> 0.39404296875
Part 6.015625
icip 0.184814453125
ants 0.1239013671875
▁were 1.388671875
▁rec 1.8779296875
ru 0.0009145736694335938
ited 1.33514404296875e-05
▁for 1.8427734375
▁six 0.484619140625
▁months 0.484619140625
▁at 1.044921875
▁two 0.223388671875
▁major 0.1219482421875
▁pain 0.040985107421875
▁relief 0.043365478515625
▁cent 0.0243682861328125
ers 0.0018205642700195312
▁in 0.024383544921875
▁Israel 0.00988006591796875
. 0.11981201171875
▁All 3.796875
▁patients 1.7236328125
▁experienced 4.0703125
▁chron 1.0908203125
ic 0.0002846717834472656
▁pain 0.289794921875
▁for 2.517578125
▁at 0.62060546875
▁least 0.00797271728515625
▁ 1.779296875
3 1.369140625
▁months 0.233154296875
. 1.1591796875
▁The 1.3388671875
▁study 1.6015625
▁included 1.6982421875
▁ 0.61962890625
8 2.9765625
9 2.48046875
0 3.013671875
▁participants 1.712890625
, 1.3447265625
▁of 2.587890625
▁which 0.56201171875
▁ 0.09979248046875
4 1.2802734375
7 2.580078125
4 2.611328125
▁( 2.865234375
5 0.0994873046875
9 4.71484375
%) 0.81884765625
▁were 0.8330078125
▁treated 3.171875
▁sole 6.78125
ly 0.0012302398681640625
▁with 0.281982421875
▁op 1.220703125
io 0.361328125
ids 0.1517333984375
, 0.560546875
▁ 0.69287109375
3 1.2626953125
2 2.251953125
9 2.470703125
▁( 0.0528564453125
4 2.525390625
1 1.3134765625
%) 0.059295654296875
▁were 1.4970703125
▁treated 0.513671875
▁with 0.388671875
▁MM 0.73486328125
, 0.377197265625
▁and 0.099853515625
▁ 0.2215576171875
7 2.021484375
7 2.322265625
▁( 0.11138916015625
8 1.828125
. 1.0068359375
6 2.240234375
%) 0.0714111328125
▁acquired 10.421875
▁both 0.591796875
▁( 4.75
Fe 9.1875
ing 1.1923828125
old 0.361572265625
▁et 0.9775390625
▁al 0.0263519287109375
., 0.1724853515625
▁ 0.0162811279296875
2 0.00843048095703125
0 0.00031304359436035156
1 0.293212890625
7 1.6767578125
). 0.050750732421875
▁The 1.162109375
▁remaining 7.5546875
▁ten 6.62109375
▁participants 1.4541015625
▁who 4.83984375
▁did 2.2109375
▁not 0.02972412109375
▁receive 2.275390625
▁ph 3.865234375
arma 0.10870361328125
ce 0.0010623931884765625
ut 1.6689300537109375e-06
ical 0.0024547576904296875
▁op 1.271484375
io 0.050262451171875
ids 0.0242462158203125
▁and 2.37890625
▁medical 1.720703125
▁mar 0.04278564453125
iju 0.00042510032653808594
ana 7.486343383789062e-05
▁were 0.48388671875
▁with 6.70703125
dra 0.11602783203125
wn 7.700920104980469e-05
▁from 0.224609375
▁the 0.1885986328125
▁analysis 2.212890625
▁in 5.15625
▁the 1.0498046875
▁research 4.0625
. 1.083984375
▁Therefore 5.01953125
, 0.0138702392578125
▁it 3.830078125
▁is 1.26953125
▁not 2.806640625
▁possible 0.6396484375
▁to 0.0109710693359375
▁compreh 5.8359375
ens 0.09051513671875
ively 0.0153350830078125
▁compare 1.2802734375
▁patients 5.109375
▁taking 3.76953125
▁medic 4.0859375
ations 0.54931640625
▁with 1.4599609375
▁those 1.068359375
▁who 0.77099609375
▁do 1.462890625
▁not 0.020233154296875
. 0.66748046875
<0x0A> 0.5849609375
The 0.8125
▁study 1.6669921875
▁conducted 4.30859375
▁a 1.8486328125
▁correlation 6.40234375
▁type 9.1640625
▁of 0.44970703125
▁research 0.9931640625
▁with 3.71875
▁variable 8.5234375
▁measures 5.296875
. 0.86328125
▁It 1.4775390625
▁evaluated 4.75390625
▁the 0.5810546875
▁inter 6.23828125
dep 2.427734375
end 0.0003857612609863281
ence 0.00719451904296875
▁of 0.58154296875
▁various 3.333984375
▁factors 0.89892578125
▁that 2.9609375
▁affected 4.05859375
▁the 0.47216796875
▁physical 6.09375
▁and 0.258544921875
▁emot 0.40087890625
ional 0.00014591217041015625
▁condition 1.4423828125
▁of 0.0377197265625
▁patients 0.75244140625
▁experien 2.9609375
cing 1.5974044799804688e-05
▁chron 0.6357421875
ic 0.0002739429473876953
▁For 14.3671875
▁pain 0.814453125
. 0.4775390625
▁example 13.09375
, 0.2010498046875
▁the 1.42578125
▁survey 6.14453125
▁showed 4.484375
▁that 0.491455078125
▁the 1.9111328125
▁ratio 6.7734375
▁of 0.1142578125
▁female 3.830078125
▁patients 1.0595703125
▁was 1.30859375
▁remark 8.2734375
ably 0.0003914833068847656
▁higher 0.2178955078125
▁in 2.517578125
▁the 0.42724609375
▁op 3.84375
i 3.48828125
ates 0.01334381103515625
▁group 0.27734375
▁compared 2.5703125
▁to 0.05828857421875
▁the 0.615234375
▁MM 0.1824951171875
▁group 0.379150390625
. 0.453125
▁In 3.416015625
▁turn 3.921875
, 0.00443267822265625
▁people 4.828125
▁on 4.84765625
▁op 2.90625
i 0.69677734375
ates 0.004886627197265625
▁were 0.978515625
▁more 1.408203125
▁to 8.6953125
▁likely 1.947265625
▁report 4.55078125
▁major 6.140625
▁de 0.609375
press 0.61328125
ive 0.0027561187744140625
▁dis 1.0498046875
orders 1.7666015625
. 1.861328125
<0x0A> 2.103515625
The 0.859375
▁question 5.71484375
na 0.88037109375
ires 0.00016880035400390625
▁used 1.93359375
▁different 7.88671875
▁variable 8.5078125
▁measures 0.6103515625
▁to 1.7373046875
▁collect 2.458984375
▁information 1.548828125
. 1.29296875
▁For 1.587890625
▁example 0.30712890625
, 0.00228118896484375
▁it 4.12890625
▁included 2.015625
▁compreh 8.203125
ensive 0.04083251953125
▁so 5.5859375
cio 0.01561737060546875
- 0.2376708984375
dem 0.11419677734375
ographic 0.0709228515625
▁data 0.94140625
: 4.8984375
▁gender 2.052734375
, 0.050689697265625
▁age 0.281005859375
, 0.038177490234375
▁country 4.16015625
, 2.7734375
▁type 4.375
▁of 0.071533203125
▁residence 3.712890625
▁( 2.630859375
urban 0.77197265625
/ 1.4931640625
r 0.1842041015625
ural 0.0008654594421386719
), 0.18359375
▁years 6.13671875
▁of 0.16455078125
▁education 0.67041015625
, 0.10107421875
▁and 1.380859375
▁employ 2.419921875
ment 0.0018911361694335938
▁status 0.68212890625
. 0.1722412109375
▁Pat 4.5625
ients 0.08099365234375
▁were 1.1923828125
▁also 0.76611328125
▁asked 0.4951171875
▁about 1.015625
▁their 0.68115234375
▁medical 2.56640625
▁history 0.57470703125
▁over 8.4609375
▁the 0.069091796875
▁years 4.6328125
▁and 1.638671875
▁the 1.49609375
▁current 2.990234375
▁presence 4.8046875
▁of 0.11309814453125
▁any 2.1875
▁severe 3.8203125
▁dise 1.8515625
ases 0.000209808349609375
▁such 4.4296875
▁as 0.01849365234375
▁heart 2.65234375
▁failure 1.7158203125
, 0.313232421875
▁di 1.578125
ab 0.0007395744323730469
etes 0.0021305084228515625
, 0.0860595703125
▁ar 4.09375
th 0.155029296875
rit 0.026092529296875
is 0.004619598388671875
, 0.03753662109375
▁and 1.1953125
▁so 0.82421875
▁on 0.040191650390625
. 0.049346923828125
▁The 1.66015625
▁third 6.73828125
▁measure 3.7265625
▁of 2.46484375
▁the 0.65869140625
▁question 1.6982421875
naire 0.287353515625
▁was 1.21484375
▁indicated 10.4140625
▁by 1.6904296875
▁information 6.7890625
▁on 2.041015625
▁any 5.7890625
▁twelve 14.0859375
- 0.29931640625
month 0.1357421875
▁and 4.83203125
▁lifetime 0.751953125
▁drug 3.28515625
▁and 1.60546875
▁alco 0.144287109375
hol 0.00014412403106689453
▁consumption 4.31640625
. 0.439208984375
▁In 3.521484375
▁addition 0.9365234375
, 0.1409912109375
▁the 0.9619140625
▁record 10.2421875
▁included 1.302734375
▁a 2.673828125
▁pain 4.48828125
▁measurement 4.9453125
▁scale 0.77978515625
▁from 4.296875
▁ 0.5009765625
0 0.292724609375
▁to 0.228271484375
▁ 0.01244354248046875
1 0.07586669921875
0 0.03521728515625
▁to 3.330078125
▁evaluate 1.568359375
▁dis 5.9140625
com 0.09271240234375
fort 0.0017642974853515625
▁feelings 7.82421875
▁during 4.29296875
▁the 0.294189453125
▁last 1.0966796875
▁month 1.6650390625
. 0.22509765625
<0x0A> 0.42138671875
Am 6.171875
ong 0.007343292236328125
▁all 2.3828125
▁participants 2.138671875
▁in 3.63671875
▁the 0.1783447265625
▁study 0.5126953125
, 0.05267333984375
▁ 0.84619140625
4 1.79296875
2 2.537109375
. 1.0556640625
2 2.21875
% 0.06829833984375
▁suffered 3.80859375
▁from 0.06585693359375
▁de 1.58203125
pression 0.240234375
, 0.94775390625
▁and 1.1083984375
▁ 0.1251220703125
3 1.4521484375
7 2.3671875
% 2.640625
▁experienced 2.169921875
▁excess 6.9609375
ive 0.02630615234375
▁anx 0.2235107421875
iety 0.0017900466918945312
. 0.35791015625
▁The 1.40234375
▁pl 10.6015625
ur 0.61376953125
ality 0.0011453628540039062
▁of 0.1123046875
▁de 2.568359375
press 1.2880859375
ive 0.0305633544921875
▁dis 2.470703125
orders 0.08172607421875
▁among 3.06640625
▁patients 1.0048828125
▁in 2.802734375
▁the 0.29443359375
▁op 0.5869140625
i 0.388671875
ates 0.001880645751953125
, 7.62890625
▁medical 4.3203125
▁mar 0.053070068359375
iju 0.0009722709655761719
ana 5.9485435485839844e-05
, 0.4033203125
▁and 0.10260009765625
▁mixed 1.7001953125
▁OP 10.7734375
MM 3.90625
▁groups 0.61181640625
▁number 8.8125
ed 0.033416748046875
▁ 0.1827392578125
5 1.6455078125
7 2.681640625
. 0.49853515625
1 2.478515625
%, 0.1983642578125
▁ 0.005794525146484375
2 2.1796875
2 2.64453125
. 0.1041259765625
3 2.2734375
%, 0.061004638671875
▁and 0.06494140625
▁ 0.00487518310546875
5 2.0234375
1 2.08203125
. 0.154541015625
4 1.8505859375
%, 0.178466796875
▁respectively 0.0261993408203125
. 0.21826171875
▁The 1.2998046875
▁pl 3.85546875
ur 0.00972747802734375
ality 4.00543212890625e-05
▁of 0.035003662109375
▁anx 0.447509765625
iety 0.0166473388671875
▁contained 10.6875
▁ 0.357177734375
4 1.12109375
8 2.353515625
. 0.166015625
4 2.1953125
% 2.02734375
▁among 2.814453125
▁OP 5.359375
▁patients 6.4453125
, 0.281005859375
▁ 0.08245849609375
2 0.94580078125
1 2.46484375
. 0.10986328125
5 2.119140625
% 0.033111572265625
▁among 0.475830078125
▁MM 0.1175537109375
▁patients 0.38623046875
, 0.0283050537109375
▁and 0.0161285400390625
▁ 0.0276947021484375
3 1.40625
8 1.900390625
. 0.1259765625
7 2.21484375
% 0.020233154296875
▁among 0.214599609375
▁OP 2.24609375
MM 0.1485595703125
▁participants 3.12109375
. 0.23193359375
▁Pat 5.1015625
ients 0.019012451171875
▁who 1.916015625
▁took 2.23046875
▁strong 9.9453125
▁op 0.7294921875
i 0.7978515625
ates 0.00293731689453125
▁were 1.177734375
▁t 9.859375
ended 0.6943359375
▁to 0.03448486328125
▁place 9.8828125
▁their 2.09765625
▁pain 1.197265625
▁on 1.9072265625
▁a 0.62939453125
▁scale 1.6279296875
▁of 0.39453125
▁ 0.1136474609375
9 2.470703125
▁to 2.212890625
▁ 0.0218048095703125
1 0.00707244873046875
0 0.00769805908203125
▁( 2.744140625
Fe 1.7255859375
ing 0.003894805908203125
old 0.0006732940673828125
▁et 0.0156097412109375
▁al 0.004398345947265625
., 0.0137176513671875
▁ 0.004058837890625
2 0.0004165172576904297
0 5.0187110900878906e-05
1 0.002025604248046875
7 0.006755828857421875
). 0.013031005859375
▁They 4.44140625
▁were 1.6513671875
▁also 0.904296875
▁an 9.21875
gu 4.75
ished 0.1597900390625
▁em 6.43359375
otion 0.00380706787109375
ally 0.0034580230712890625
▁and 1.1064453125
▁react 7.484375
ed 0.029541015625
▁rad 9.328125
ically 0.0018835067749023438
▁neg 4.6875
atively 0.0019168853759765625
▁to 0.1668701171875
▁almost 5.61328125
▁all 1.41015625
▁survey 3.841796875
▁questions 0.2325439453125
. 0.30517578125
▁Pat 3.80078125
ients 0.0052947998046875
▁who 1.2109375
▁only 5.4296875
▁took 1.2685546875
▁MM 0.3603515625
▁or 3.275390625
▁mixed 2.505859375
▁medic 1.5341796875
ations 0.23486328125
▁course 12.890625
▁had 2.794921875
▁a 1.3330078125
▁significantly 2.900390625
▁more 3.0546875
▁stable 2.71875
▁emot 0.89794921875
ional 0.0013875961303710938
▁state 0.54638671875
▁and 1.05078125
▁cop 6.86328125
ed 0.0278167724609375
▁with 0.399658203125
▁pain 0.79248046875
▁more 1.7509765625
▁manage 6.8203125
able 1.140625
. 0.266845703125
<0x0A> 0.26416015625
One 5.05859375
▁of 0.208740234375
▁the 0.00772857666015625
▁major 2.6953125
▁limitations 2.244140625
▁is 3.0859375
▁the 0.50341796875
▁ins 4.68359375
u 0.0643310546875
fficient 0.040557861328125
ly 3.3828125
▁high 3.171875
▁response 3.232421875
▁rate 0.10833740234375
, 2.619140625
▁ 4.58203125
5 1.6259765625
7 2.884765625
% 2.30078125
▁instead 6.74609375
▁of 0.0196685791015625
▁ 0.54150390625
7 1.9619140625
0 0.420654296875
% 1.4326171875
▁( 2.3984375
Fe 0.5703125
ing 0.0024585723876953125
old 0.00040030479431152344
▁et 0.0111083984375
▁al 0.0006971359252929688
., 0.00823974609375
▁ 0.0033473968505859375
2 0.00024139881134033203
0 0.00016868114471435547
1 0.0006289482116699219
7 0.00495147705078125
). 0.01264190673828125
▁It 1.7412109375
▁can 2.92578125
▁be 0.89208984375
▁fairly 8.4921875
▁explained 1.8046875
▁by 0.1951904296875
▁the 0.26025390625
▁weak 7.3984375
▁focus 7.03515625
▁of 0.6982421875
▁respond 5.76953125
ents 0.09722900390625
▁who 3.4375
▁have 3.806640625
▁overcome 8.078125
▁severe 1.986328125
▁pain 0.501953125
▁sens 7.58984375
ations 0.1788330078125
▁and 0.86572265625
▁de 4.84765625
press 0.8232421875
ive 0.045379638671875
▁episodes 2.318359375
. 0.50830078125
▁It 2.783203125
▁is 0.78564453125
▁not 2.5625
▁clear 3.345703125
▁how 1.8046875
▁to 3.396484375
▁use 4.96875
▁these 2.927734375
▁statistics 3.98828125
, 2.994140625
▁as 0.6171875
▁they 1.91015625
▁still 5.234375
▁may 4.49609375
▁be 1.34765625
▁relevant 5.8125
▁for 1.7685546875
▁the 1.8671875
▁overall 4.6484375
▁analysis 2.625
. 0.87841796875
